Literature DB >> 18484142

The effects of endothelin receptor blockade by bosentan on the healing of a bowel anastomosis in an experimental Crohn's disease model.

Cuneyt Kirkil1, Ziya Cetinkaya, Bilal Ustundag, Nusret Akpolat, Refik Ayten, Nurullah Bulbuller.   

Abstract

OBJECTIVE: It was previously described that endothelins may contribute to the pathogenesis of Crohn's disease. In this study, it was aimed to investigate the effects of endothelin receptor blockade by bosentan on the healing of a bowel anastomosis in an experimental Crohn's disease model.
MATERIAL AND METHODS: Twenty-eight Sprague-Dawley rats were divided into four groups. Groups I and II were used as sham-operated and control groups, respectively. Bowel inflammation induced by intrajejunal injection of iodoacetamide in groups III and IV. Rats in group IV were treated with oral preparation of bosentan 60 mg/kg/day. Three days after induction of the inflammation, partial resection of test loop and anastomosis was performed. Re-laparotomy was performed, anastomosis bursting pressures and peritonitis scores were measured, and tissue samples were obtained for the measurements of tissue hydroxylproline level and mucosal damage index 4 days later.
RESULTS: The mean mucosal damage index and peritonitis score of group IV were significantly lower, and the mean tissue hydroxyproline level and anastomotic bursting pressure of group IV were significantly higher than those of group III.
CONCLUSION: The blockade of endothelin receptors by bosentan decreases the severity of iodoacetamide induced intestinal inflammation, increases the wound healing in the inflamed intestinal tissue, and decreases the severity of peritonitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18484142     DOI: 10.1007/s11605-008-0527-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  26 in total

1.  High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis.

Authors:  S H Murch; C P Braegger; W C Sessa; T T MacDonald
Journal:  Lancet       Date:  1992-02-15       Impact factor: 79.321

2.  The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid.

Authors:  J F WOESSNER
Journal:  Arch Biochem Biophys       Date:  1961-05       Impact factor: 4.013

3.  Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice.

Authors:  B Hocher; A Schwarz; K A Fagan; C Thöne-Reineke; K El-Hag; H Kusserow; S Elitok; C Bauer; H H Neumayer; D M Rodman; F Theuring
Journal:  Am J Respir Cell Mol Biol       Date:  2000-07       Impact factor: 6.914

4.  Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells.

Authors:  M Yoshizumi; H Kurihara; T Morita; T Yamashita; Y Oh-hashi; T Sugiyama; F Takaku; M Yanagisawa; T Masaki; Y Yazaki
Journal:  Biochem Biophys Res Commun       Date:  1990-01-15       Impact factor: 3.575

5.  VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.

Authors:  S Kanazawa; T Tsunoda; E Onuma; T Majima; M Kagiyama; K Kikuchi
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

6.  Profibrotic effects of endothelin-1 via the ETA receptor in cultured human cardiac fibroblasts.

Authors:  Sassan Hafizi; John Wharton; Adrian H Chester; Magdi H Yacoub
Journal:  Cell Physiol Biochem       Date:  2004

7.  Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing.

Authors:  D C Rockey; J J Chung
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

8.  Endothelin concentrations in experimental sepsis: profiles of big endothelin and endothelin 1-21 in lethal peritonitis in rats.

Authors:  R Lundblad; K E Giercksky
Journal:  Eur J Surg       Date:  1995-01

9.  Crohn's disease and anastomotic recurrence: microvascular ischaemia and anastomotic healing in an animal model.

Authors:  M J Osborne; M Hudson; C Piasecki; A P Dhillon; A A Lewis; R E Pounder; A J Wakefield
Journal:  Br J Surg       Date:  1993-02       Impact factor: 6.939

10.  Effect of volume support, antibiotic therapy, and monoclonal antiendotoxin antibodies on mortality rate and blood concentrations of endothelin and other mediators in fulminant intra-abdominal sepsis in rats.

Authors:  R Lundblad; K E Giercksky
Journal:  Crit Care Med       Date:  1995-08       Impact factor: 7.598

View more
  1 in total

Review 1.  Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases.

Authors:  Si-Nan Lin; Ren Mao; Chenchen Qian; Dominik Bettenworth; Jie Wang; Jiannan Li; David H Bruining; Vipul Jairath; Brian G Feagan; Min-Hu Chen; Florian Rieder
Journal:  Physiol Rev       Date:  2021-09-27       Impact factor: 37.312

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.